Clinical and Biological Database in Colon Cancer and Colic Tumors
BCBCOLON
Prospective, Multicenter, Clinical and Biological Database Set-up in Colon Cancer and Colic Tumors
1 other identifier
interventional
600
1 country
2
Brief Summary
Developement of a clinical and biological database in colon cancer and colic tumors in order to better understand tumor invasion and metastatic scattering processes. The investigators hope that a better understanding of tumoral invasion process will lead to the discovery of new biomarkers and new drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2018
CompletedFirst Submitted
Initial submission to the registry
June 5, 2019
CompletedFirst Posted
Study publicly available on registry
June 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
ExpectedFebruary 12, 2025
February 1, 2025
7.2 years
June 5, 2019
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of clinical risk factors for colorectal cancer
Until the study completion : 6 years
Number of biological risk factors for colorectal cancer
Until the study completion : 6 years
Study Arms (1)
Biological collection
EXPERIMENTALFor all the patients include in the study : samples of blood samples collected before or after surgery but also samples in paraffin-embedded tissue sections. In parallel to this biological collection, standardized clinical data will be entered into a database
Interventions
The biological collection will also include samples of blood samples collected before or after surgery but also samples frozen and/or paraffin-embedded tissue sections.
Eligibility Criteria
You may qualify if:
- Patient undergoing colon cancer surgery (stage I, II, III and IV)
- Patient operated for liver or lung or peritoneal carcinomatosis metastases originating from colon cancer
- Patient operated for pre-neoplastic lesion (adenomatous polyp /villous adenoma polyp),
- Patient with familial polyposis eligible for colectomy
- Age \> 18 years
- Signed informed consent
You may not qualify if:
- Patient not affiliated to Social Protection system
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- Patient under guardianship
- Minor patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHRU de Montpellier
Montpellier, Hérault, 34298, France
Institut Régional du cancer de Montpellier
Montpellier, 34298, France
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ERIC ASSENAT, M.D
Institut régional du cancer de Montpellier
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2019
First Posted
June 6, 2019
Study Start
September 19, 2018
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2030
Last Updated
February 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share